Most Viewed Articles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Most Viewed Articles

First Seasonal Influenza Vaccine Produced in Cell Culture Approved in US

November 26, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Novartis announced that it has received FDA approval for a seasonal influenza vaccine produced in cell culture, the first seasonal vaccine produced by this method to be approved in the US.

FDA Adopts Final Version of Q11 Guidance

November 20, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

FDA announced the availability of the guidance “Q11 Development and Manufacture of Drug Substances†in the Nov. 20, 2011 edition of the Federal Register.

Raid Captures 82 Million Doses of Counterfeit Drugs in Africa

November 12, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

An operation spanning 16 African countries and conducted by the World Customs Organization (WCO) in partnership with the Institute of Research against Counterfeit Medicines (IRACM) led to the seizure of more than 82 million doses of counterfeit medicines.

Watson Completes Acquisition of Actavis, Will Take Actavis Name

November 6, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Watson Pharmaceuticals has completed its EUR 4.25 billion ($5.4 billion) acquisition of the Actavis Group. The combination creates the world's third largest generic-drug pharmaceutical company, with anticipated pro forma combined 2012 revenues in excess of $8 billion, according to Watson.

EC Approves Europe's First Gene Therapy

November 6, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

The European Commission has issued final approval for Europe's first gene therapy—a treatment for a rare genetic disorder that currently has no other treatment options.

Boehringer Ingelheim Settles False Claims Act Allegations for $95 Million

November 5, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Boehringer Ingelheim has agreed to pay $95 million to settle allegations that it improperly promoted four of its drugs.

Mean Kinetic Relative Humidity: A New Concept for Assessing the Impact of Variable Relative Humidity on Pharmaceuticals

November 2, 2012

Pharmaceutical Technology

This article introduces"mean kinetic relative humidity" for evaluating the impact of humidity variability.

An Industry Perspective on Harmonization and Implementation of ICH and USP Requirements

November 2, 2012

Pharmaceutical Technology

The US Pharmacopeia's revised General Chapters on elemental impurity limits and testing procedures are set to take effect in December 2012.

A Troubleshooting Guide for Topical Drug Manufacturing

November 2, 2012

Pharmaceutical Technology

Consider critical process parameters and strategies to optimize the manufacturing process.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here